4//SEC Filing
NANOPHASE TECHNOLOGIES CORPORATION 4
Accession 0001209191-15-018879
$SLSNCIK 0000883107operating
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:55 AM ET
Size
16.9 KB
Accession
0001209191-15-018879
Insider Transaction Report
Form 4
CESARIO FRANK
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-02-25$0.41/sh+26,000$10,790→ 83,783 total - Exercise/Conversion
Common Stock
2015-02-25$0.30/sh+27,333$8,200→ 57,783 total - Exercise/Conversion
Common Stock (right to buy)
2015-02-25$0.41/sh−26,000$10,790→ 13,000 totalExercise: $0.41From: 2014-02-14Exp: 2023-02-14→ Common Stock (26,000 underlying) - Exercise/Conversion
Common Stock (right to buy)
2015-02-25$0.30/sh−27,333$8,200→ 13,667 totalExercise: $0.30From: 2013-08-07Exp: 2022-08-07→ Common Stock (27,333 underlying)
Holdings
- 20,000
Common Stock (right to buy)
Exercise: $1.07From: 2010-06-24Exp: 2019-06-24→ Common Stock (20,000 underlying) - 20,000
Common Stock (right to buy)
Exercise: $1.70From: 2011-05-03Exp: 2020-05-03→ Common Stock (20,000 underlying) - 31,000
Common Stock (right to buy)
Exercise: $1.26From: 2012-05-02Exp: 2021-05-02→ Common Stock (31,000 underlying) - 40,000
Common Stock (right to buy)
Exercise: $0.52From: 2015-02-13Exp: 2024-02-13→ Common Stock (40,000 underlying) - 36,000
Common Stock (right to buy)
Exercise: $0.44From: 2016-02-18Exp: 2025-02-18→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
Documents
Issuer
NANOPHASE TECHNOLOGIES CORPORATION
CIK 0000883107
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000883107
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:55 AM ET
- Size
- 16.9 KB